27452524|t|CD84 mediates CLL - microenvironment interactions
27452524|a|Chronic lymphocytic leukemia (CLL) is a malignant disease of small mature lymphocytes. Signals from the CLL microenvironment promote progression of the disease and induce drug resistance. This phenomenon is largely dependent on direct contact between the malignant B cells and stromal cells. CD84 belongs to the signaling lymphocyte activation molecule family of immunoreceptors, which self-associates, forming an orthogonal homophilic dimer. We therefore hypothesized that CD84 may bridge between CLL cells and their microenvironment, promoting cell survival. Our in vitro results show that CD84 expressed on CLL cells interact with CD84 expressed on cells in their microenvironment, inducing cell survival in both sides. Blocking CD84 in vitro and in vivo disrupt the interaction of CLL cells with their microenvironment, resulting in induced cell death. Thus, our findings suggest novel therapeutic strategies based on the blockade of this CD84 - dependent survival pathway.
27452524	0	4	CD84	T116,T129	C0666283
27452524	14	17	CLL	T191	C0023434
27452524	20	36	microenvironment	T070	C3494179
27452524	37	49	interactions	T043	C0007582
27452524	50	78	Chronic lymphocytic leukemia	T191	C0023434
27452524	80	83	CLL	T191	C0023434
27452524	90	107	malignant disease	T047	C0442867
27452524	117	135	mature lymphocytes	T025	C1513026
27452524	137	144	Signals	T067	C1710082
27452524	154	157	CLL	T191	C0023434
27452524	158	174	microenvironment	T070	C3494179
27452524	175	182	promote	T052	C0033414
27452524	183	209	progression of the disease	T046	C0242656
27452524	214	220	induce	T169	C0205263
27452524	221	236	drug resistance	T038	C0013203
27452524	243	253	phenomenon	T067	C1882365
27452524	265	274	dependent	T080	C0851827
27452524	305	322	malignant B cells	T191	C0079731
27452524	327	340	stromal cells	T025	C1518246
27452524	342	346	CD84	T116,T129	C0666283
27452524	362	409	signaling lymphocyte activation molecule family	T116,T123	C4277631
27452524	413	428	immunoreceptors	T116,T192	C0597357
27452524	436	451	self-associates	T044	C1819957
27452524	464	491	orthogonal homophilic dimer	T104	C0596448
27452524	524	528	CD84	T116,T129	C0666283
27452524	548	551	CLL	T191	C0023434
27452524	552	557	cells	T025	C0007634
27452524	568	584	microenvironment	T070	C3494179
27452524	586	595	promoting	T052	C0033414
27452524	596	609	cell survival	T043	C0007620
27452524	615	623	in vitro	T080	C1533691
27452524	624	631	results	T169	C1274040
27452524	642	656	CD84 expressed	T045	C1171362
27452524	660	663	CLL	T191	C0023434
27452524	664	669	cells	T025	C0007634
27452524	670	678	interact	T169	C1704675
27452524	684	698	CD84 expressed	T045	C1171362
27452524	702	707	cells	T025	C0007634
27452524	717	733	microenvironment	T070	C3494179
27452524	735	743	inducing	T169	C0205263
27452524	744	757	cell survival	T043	C0007620
27452524	773	781	Blocking	T169	C0332206
27452524	782	786	CD84	T116,T129	C0666283
27452524	787	795	in vitro	T080	C1533691
27452524	800	807	in vivo	T082	C1515655
27452524	808	815	disrupt	T080	C0332454
27452524	820	831	interaction	T169	C1704675
27452524	835	838	CLL	T191	C0023434
27452524	839	844	cells	T025	C0007634
27452524	856	872	microenvironment	T070	C3494179
27452524	874	886	resulting in	T169	C0332294
27452524	887	894	induced	T169	C0205263
27452524	895	905	cell death	T043	C0007587
27452524	917	925	findings	T033	C0243095
27452524	934	939	novel	T080	C0205314
27452524	940	951	therapeutic	T169	C0302350
27452524	976	984	blockade	T121,T196	C3540676
27452524	993	997	CD84	T116,T129	C0666283
27452524	1000	1009	dependent	T080	C0851827
27452524	1010	1018	survival	T043	C0007620
27452524	1019	1026	pathway	T044	C1704259